How do I buy Medline Inc. Class A common stock (MDLN) stock?

Buying Medline Inc. Class A common stock (MDLN) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "MDLN", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy MDLN by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if MDLN is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Medline Inc. Class A common stock (MDLN) Stock

Q: What is the minimum investment for MDLN on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Medline Inc. Class A common stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NYSE · MDLN

Trade MDLN

Key stats

Market cap: $37.04B
Price / Earnings ratio: 95.1x
EPS (TTM): -$0.01
Volume: Loading
52-week high: $50.88
52-week low: $31.37
Next earnings report: 18 Nov 2026

Source: third-party data provider, as of November 13, 2026

Compare with MDLN

Technical indicators

RSI 14: 75.19
MACD 12/26/9: 1.57
EMA 9 of MACD: 0.67
MACD histogram: 0.90
SMA 50: $35.15; Price above SMA 50
EMA 50: $36.03; Price above EMA 50
SMA 200: $39.42; Price above SMA 200
EMA 200: $39.31; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 7 analyst ratings

Strong Sell0

Sell0

Hold0

Buy7

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2022

2023

2024

2025

34B23B11B0

Debt & Balance Sheet

Total assets

Total liabilities

2022

2023

2024

2025

46B30B15B0

Revenue to Profit

2025

$28.4B

Revenue

$0.0

Cost of revenue

$7.5B

Gross profit

$0.0

Operating expenses

$1.2B

Net income

Earnings

EPS forecast

Actual EPS

Q1FY26

Q2FY26

Q3FY26

The market has no earnings per share expectations for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Medline Inc. Class A common stock

The mission is to make healthcare run better by delivering improved clinical, financial, and operational outcomes. Recognized as the largest provider of medical-surgical (“med-surg”) products and supply chain solutions based on total net sales, the organization serves all points of care. It delivers mission-critical products used daily across hospitals, surgery centers, physician offices, and post-acute facilities. Through two primary segments—Medline Brand and Supply Chain Solutions—the company offers approximately 335,000 med-surg products. These include surgical and procedural kits, gloves and protective apparel, urological and incontinence care products, wound care solutions, and consumable laboratory and diagnostic items.

SectorHealthcare

IndustryMedical Instruments & Supplies

Employees45,000

CEOMr. James M. Boyle

IPO DateDec 17, 2025

HeadquartersNorthfield, IL

Key Executives

Name	Title	Year Born
Mr. James M. Boyle	CEO & Director	1972
Mr. Michael B. Drazin	Chief Financial Officer	1975
Mr. Douglas P. Golwas	Chief Commercial Officer	1969
Ms. Jessi L. Corcoran	Chief Accounting Officer	1983
Mr. Marshall Lancaster	Chief Information Officer	—
Ms. Karen M. King	Global Head Investor Relations	—
Mr. Alex M. Liberman	Chief Legal Officer	1965
Mr. Ben Fox	Vice President of Corporate Communications	—
Ms. Jenny Lee	Chief Marketing Officer	—
Mr. Christopher P. Shryock	Chief Human Resources Officer	1982

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2025												+2.4
2026	+8.8	+5.5	-2.9	+1.1	-18.3	+10.3	-5.9	-13.4	-1.2	-8.1	+25.4

Stocks in the same sector

FAQ

Buying Medline Inc. Class A common stock (MDLN) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "MDLN", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy MDLN by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Medline Inc. Class A common stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Medline Inc. Class A common stock (MDLN) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track MDLN's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Medline Inc. Class A common stock (MDLN) Stock

Key stats

Compare with MDLN

Recent news

MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 12.8% Share Drop

MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 12.8% Share Drop

MDLN Stock Drop Alert: Medline Inc.'s Stock Drops 13% over Product Quality Issues Triggering Securities Fraud Investigation by BFA Law

MDLN Stock Drop Alert: Medline Inc.'s Stock Drops 13% over Product Quality Issues Triggering Securities Fraud Investigation by BFA Law

NASDAQ: MDLN Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

NASDAQ: MDLN Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

Medline Q2 Earnings Call Highlights

Medline Q2 Earnings Call Highlights

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 12.8% Share Drop

MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 12.8% Share Drop

MDLN Stock Drop Alert: Medline Inc.'s Stock Drops 13% over Product Quality Issues Triggering Securities Fraud Investigation by BFA Law

MDLN Stock Drop Alert: Medline Inc.'s Stock Drops 13% over Product Quality Issues Triggering Securities Fraud Investigation by BFA Law

NASDAQ: MDLN Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

NASDAQ: MDLN Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

Medline Q2 Earnings Call Highlights

Medline Q2 Earnings Call Highlights

Here's What Key Metrics Tell Us About Medline (MDLN) Q2 Earnings

Here's What Key Metrics Tell Us About Medline (MDLN) Q2 Earnings

These Two Medical Stocks Are Screaming Sell — Here's What Happened

These Two Medical Stocks Are Screaming Sell — Here's What Happened

Access Vascular and Medline Enter Multi-Year Agreement to Launch Cobranded Next-Generation Vascular Access Catheters

Access Vascular and Medline Enter Multi-Year Agreement to Launch Cobranded Next-Generation Vascular Access Catheters

ICUI or MDLN: Which Is the Better Value Stock Right Now?

ICUI or MDLN: Which Is the Better Value Stock Right Now?

Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Medline Industries, Inc. (MDLN) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Medline Industries, Inc. (MDLN) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

About Medline Inc. Class A common stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade